Legend Biotech (LEGN) Enterprise Value (2019 - 2025)
Legend Biotech (LEGN) posted Enterprise Value of -$286.7 million for Q4 2025, down 2.8% on a QoQ basis from -$278.9 million in Q3 2025, and little changed year-over-year from -$286.6 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Enterprise Value data on file, last reported at -$286.7 million in Q4 2025.
- In Q4 2025, Enterprise Value changed 0.02% year-over-year to -$286.7 million; the TTM figure through Dec 2025 stood at -$286.7 million (changed 0.02% YoY), while the FY2025 annual figure was -$286.7 million, changed 0.02% from the prior year.
- Enterprise Value retreated to -$286.7 million in Q4 2025, from -$278.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$243.5 million in Q2 2024 and bottomed at -$1.4 billion in Q2 2023.
- A 5-year average of -$647.4 million and a median of -$457.5 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value slumped 446.63% — and 2024, when it soared 82.84%.
- Year by year, Enterprise Value stood at -$690.4 million in 2021, then tumbled by 40.74% to -$971.6 million in 2022, then plunged by 31.57% to -$1.3 billion in 2023, then soared by 77.57% to -$286.8 million in 2024, then grew by 0.02% to -$286.7 million in 2025.
- The last three Enterprise Value figures came in at -$286.7 million (Q4 2025), -$278.9 million (Q3 2025), and -$266.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -901.90 Mn |
| Sep 30, 2025 | -278.89 Mn |
| Jun 30, 2025 | -266.66 Mn |
| Mar 31, 2025 | -441.77 Mn |
| Dec 31, 2024 | -286.77 Mn |
| Sep 30, 2024 | -459.28 Mn |
| Jun 30, 2024 | -243.45 Mn |
| Mar 31, 2024 | -1.05 Bn |
| Dec 31, 2023 | -1.28 Bn |
| Sep 30, 2023 | -1.15 Bn |
| Jun 30, 2023 | -1.42 Bn |
| Mar 31, 2023 | -845.76 Mn |
| Dec 31, 2022 | -971.63 Mn |
| Sep 30, 2022 | -812.73 Mn |
| Jun 30, 2022 | -379.78 Mn |
| Mar 31, 2022 | -788.93 Mn |
| Dec 31, 2021 | -690.38 Mn |
| Sep 30, 2021 | -505.73 Mn |
| Jun 30, 2021 | -455.69 Mn |
| Mar 31, 2021 | -455.69 Mn |
| Dec 31, 2020 | -456.07 Mn |
| Sep 30, 2020 | -83.37 Mn |
| Jun 30, 2020 | -83.36 Mn |
| Mar 31, 2020 | -168.80 Mn |
| Dec 31, 2019 | -83.36 Mn |
| Sep 30, 2019 | -210.17 Mn |
| Jun 30, 2019 | -210.17 Mn |